214 related articles for article (PubMed ID: 17609667)
1. MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells.
Sodek KL; Ringuette MJ; Brown TJ
Br J Cancer; 2007 Aug; 97(3):358-67. PubMed ID: 17609667
[TBL] [Abstract][Full Text] [Related]
2. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
Poincloux R; Lizárraga F; Chavrier P
J Cell Sci; 2009 Sep; 122(Pt 17):3015-24. PubMed ID: 19692588
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells.
Wu M; Xu G; Xi L; Wei J; Song A; Han Z; Zhou J; Wang S; Zhu T; Zhang A; Lu Y; Ma D
Oncol Rep; 2006 Feb; 15(2):501-5. PubMed ID: 16391876
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia promotes HO-8910PM ovarian cancer cell invasion via Snail-mediated MT1-MMP upregulation.
Sun L; Lin P; Qin Z; Liu Y; Deng LL; Lu C
Exp Biol Med (Maywood); 2015 Nov; 240(11):1434-45. PubMed ID: 25681470
[TBL] [Abstract][Full Text] [Related]
5. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
6. Coordinate action of membrane-type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion.
Sato H; Takino T
Cancer Sci; 2010 Apr; 101(4):843-7. PubMed ID: 20148894
[TBL] [Abstract][Full Text] [Related]
7. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
8. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
9. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells.
Koshikawa N; Mizushima H; Minegishi T; Eguchi F; Yotsumoto F; Nabeshima K; Miyamoto S; Mekada E; Seiki M
Cancer Sci; 2011 Jan; 102(1):111-6. PubMed ID: 20946474
[TBL] [Abstract][Full Text] [Related]
12. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of MT1-MMP antisense nucleotide on invasion of human highly metastatic ovarian cancer cell line SW626].
Wu MF; Liao GN; Jia P; Xi L; Lu YP; Ma D
Ai Zheng; 2004 Nov; 23(11):1263-6. PubMed ID: 15522170
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
[TBL] [Abstract][Full Text] [Related]
15. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
Wang C; Chen Z; Li Z; Cen J
Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
[TBL] [Abstract][Full Text] [Related]
16. ATAT1/MEC-17 acetyltransferase and HDAC6 deacetylase control a balance of acetylation of alpha-tubulin and cortactin and regulate MT1-MMP trafficking and breast tumor cell invasion.
Castro-Castro A; Janke C; Montagnac G; Paul-Gilloteaux P; Chavrier P
Eur J Cell Biol; 2012; 91(11-12):950-60. PubMed ID: 22902175
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.
Okada Y
Verh Dtsch Ges Pathol; 2000; 84():33-42. PubMed ID: 11217446
[TBL] [Abstract][Full Text] [Related]
18. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
Yamaguchi H; Takeo Y; Yoshida S; Kouchi Z; Nakamura Y; Fukami K
Cancer Res; 2009 Nov; 69(22):8594-602. PubMed ID: 19887621
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
[TBL] [Abstract][Full Text] [Related]
20. Polarized MT1-MMP-CD44 interaction and CD44 cleavage during cell retraction reveal an essential role for MT1-MMP in CD44-mediated invasion.
Marrero-Diaz R; Bravo-Cordero JJ; Megías D; García MA; Bartolomé RA; Teixido J; Montoya MC
Cell Motil Cytoskeleton; 2009 Jan; 66(1):48-61. PubMed ID: 19023892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
